Aim
===

To assess colorectal cancer (CRC) risk during colonoscopy surveillance in a cohort of patients with the serrated polyposis syndrome (SPS).

Method
======

Colonoscopy and histology records from January 2000 to time of interview for 67 New Zealand patients, meeting WHO criteria for a diagnosis of SPS and enrolled in the Genetics of Serrated Neoplasia study, were reviewed. Polyp demographics, smoking status and family history of cancer were recorded.

Results
=======

Of 67 patients 18 presented with CRC (mean age 57yrs, 12 Female). Only one of 18 reported a first degree relative (FDR) with CRC. Over a median follow-up of 8 years from time of surgery with an average interval of 16 months between colonoscopies, two patients developed metachronous CRC: one identified at prophylactic completion colectomy and one in association with first diagnosis of SPS 19 yrs following initial CRC and 30 months after a previous colonoscopy. Of 45 patients with polyps alone (mean age 48 yrs, 27 female) followed for a median of 9 years with an average interval of 15 months between colonoscopies, none developed CRC despite 33 having multiple pan colonic polyps. Of these 33, 70% had an adenoma, 18 % a sessile serrated polyp and 53 % polyps \>10 mm. A FDR with CRC was reported in 14/45 (31%). Four patients with multiple pan colonic polyps and no FDR with CRC underwent prophylactic subtotal colectomy (mean age 58 yrs, 3 females) after being followed for a median of 5 years with an average interval between colonoscopies of 8 months. All had adenomas and one a sessile serrated polyp. No significant smoking effect was seen in any group.

Conclusion
==========

If endoscopic control is feasible, SPS patients can be judiciously managed by frequent surveillance colonoscopy.
